BusinessNew Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment DecisionsBy Nasdaq OMXApr 30, 2018, 1:20 PM UTC
BusinessBiodesix Announces PD-L1 Collaboration with Professor Fred R. HirschBy Nasdaq OMXJan 31, 2018, 2:01 PM UTC
BusinessLung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib TherapyBy Nasdaq OMXJul 10, 2017, 5:09 PM UTC
BusinessBiodesix® and Positive Bioscience Announce Partnership to Bring Cancer Tests to IndiaBy Nasdaq OMXJun 12, 2017, 4:38 PM UTC
